LabCorp is first to provide consumers with secure access to their diagnostic test results through CommonHealth

Android Phone Users Now Have Easy Access to Their Test Results as Popularity of Telehealth Rises

BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 13, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and The Commons Project, a non-profit public trust dedicated to building global digital services and platforms for the common good, today announced a strategic partnership to allow people to securely access their LabCorp test results via CommonHealth, the privacy-preserving Android app that enables users to safely collect, store, and use their personal health information. LabCorp is the first major commercial lab to integrate with CommonHealth, which is also working with a wide range of other health care providers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201013005618/en/

“The healthcare landscape has evolved dramatically over the past few months, with consumers requesting faster and easier access to their health information,” said Mark Wright, senior vice president of IT Customer Products at LabCorp. “By enabling patients to integrate their test results with CommonHealth, consumers can securely access their results and share them at their discretion with doctors, telehealth providers, schools, employers and others whom they may want to have access to this information.”

Developed by a team of clinicians, public health experts, technologists and scientists, CommonHealth – available for download via Google Play – allows users of Android devices to securely collect and store their lifelong health data on their mobile devices and share it with those they trust. CommonHealth extends health data portability to the 52% of Americans using Android phones.

CommonHealth users now have a convenient, secure option for accessing their LabCorp test results on their Android phones. CommonHealth is distinguished from other apps that allow sharing of clinical data in that it is operated as a non-profit public service with a robust privacy-protecting model for how data is shared and how apps and partners are vetted and held accountable.

“There has never been more need for people to safely access and manage their health data,” said Paul Meyer, CEO of The Commons Project. “With the acceleration of remote medicine and telehealth, patients and providers need easy access to trusted lab data to make informed medical decisions.”

CommonHealth aggregates an individual’s health information from multiple sources and allows them to share it with apps and services they trust. Individuals have the capability to determine the type of information and with whom to share it, and can also change their permissions to remove providers or any data type at any time. Additionally, without a user’s explicit consent, data accessed and stored with CommonHealth is not shared with any third-party.

“CommonHealth allows people to securely gather their health data right on their phones – not wrestle with complicated and closed off electronic health record systems,” said JP Pollak, PhD, Co-Founder and Chief Architect of The Commons Project. “This integration with LabCorp, a world leader in diagnostic testing, is the latest example of how The Commons Project is working to give more people access and control over their health data, in a way that puts their interests first.”

About LabCorp

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostics solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care. LabCorp reported revenue of more than $11.5 billion in 2019.

To learn more about LabCorp, visit www.LabCorp.com, and to learn more about LabCorp’s Covance drug development business, visit www.Covance.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements, including but not limited to statements with respect to scientific collaborations, customer contracts and relationships, the anticipated benefits of such collaboration and relationships, and the expected impact that the various collaborations and customer relationships may have on the Company’s financial results. Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the Company’s control, including without limitation, the Company’s ability to establish and maintain strategic partnerships and other scientific collaborations, competitive actions in the marketplace, and other unforeseen changes and general uncertainties in the marketplace, changes in government regulations, including healthcare reform, customer purchasing decisions, including changes in payer regulations or policies, adverse actions of governmental and other third-party payers, patient safety issues, changes in testing guidelines or recommendations. These factors, in some cases, have affected and in the future (together with other factors) could affect the Company’s ability to implement the Company’s business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the Company’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the Company’s other filings with the SEC.

About The Commons Project

The Commons Project is a non-profit public trust building global digital services and platforms for the common good. Founded with support from The Rockefeller Foundation and based in Switzerland, it was established to build and operate the shared platforms and services that neither governments nor tech companies are well positioned to create. The Commons Project’s public trust governance structure is designed to ensure that people’s interests are served above all. Learn more at thecommonsproject.org.

# # #

View source version on businesswire.com: https://www.businesswire.com/news/home/20201013005618/en/

Media: Donald Von Hagen — 336-436-8263
[email protected]

Investors: Clarissa Willett — 336-436-5076
[email protected]

Source: LabCorp